Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Steele ElisaDirector | Option exercise | M | — 61.0K sh | Jul 7, 2026 |
| 9 | Malkoski Kristine KayPresident, Learning & Dev. | Option exercise | M | — 75.2K sh | Jul 7, 2026 traded Jul 5, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 151.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 151.8K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $131K 3,487 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 18.38M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $45K 182 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $34K 138 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Cannito Peter Anthony JrDirector, Chairman and CEO | Tax withholding | F | $217K 19.2K sh | Jul 7, 2026 traded Jul 3, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $3,002 12 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 8 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Derivative conversion | C | — 18.38M sh | Jul 7, 2026 traded Jul 2, 2026 |
| 8 | Potts James REVP Gen Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $133K 3,490 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 8 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $128K 4,250 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 7 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $374K 25.1K sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $63K 460 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $97K 731 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $80K 593 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 6 | Eltoukhy AdamSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $135K 3,653 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 6 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $149K 1,040 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $200K 1,388 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 6 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $114K 869 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 5 | Huet Melanie ArlenePresident, Home & Com - Home | Option exercise | M | — 17.2K sh | Jul 7, 2026 traded Jul 5, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | Option exercise | M | — 5,405 sh | Jul 7, 2026 traded Jul 4, 2026 |
| 5 | Xu Cong ClaireSVP, Clinical Development | Option exercise | M | — 12.4K sh | Jul 7, 2026 traded Jul 4, 2026 |
| 5 | Randle Race A.CEO | Tax withholding | F | — 3,437 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 5 | Edmunds ChrisChief Financial Officer | Tax withholding | F | $29K 2,522 sh | Jul 7, 2026 traded Jul 3, 2026 |
| 4 | Abrahamsen Danielle NicoleChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $38K 254 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 4 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $261K 7,163 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $9,453 73 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $38K 282 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $48K 345 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 3 | Fitzpatrick JenniferChief Legal Officer | Option exercise · 10b5-1 plan | M | — 10.3K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 3 | Kazmaier Gerrit SPresident, Prod. and Tech. | Open-market sale · 10b5-1 plan | SELL | $43K 300 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 2 | Sankar ShyamSee Remarks | Derivative conversion · 10b5-1 plan | C | — 35.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 2 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Derivative conversion · 10b5-1 plan | C | — 103.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 1 | Tang StanleyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 23.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 1 | Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY | Open-market sale · 10b5-1 plan | SELL | $35K 2,547 sh | Jul 7, 2026 traded Jul 7, 2026 |
| 1 | Tang StanleyDirector | Other acquisition or disposition · 10b5-1 plan | J | — 23.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 1 | Kazmaier Gerrit SPresident, Prod. and Tech. | Tax withholding · 10b5-1 plan | F | $1.22M 8,976 sh | Jul 7, 2026 traded Jul 5, 2026 |
| 0 | Fitzpatrick JenniferChief Legal Officer | Option exercise · 10b5-1 plan | M | $63K 10.3K sh | Jul 7, 2026 traded Jul 6, 2026 |